Kathy Park

Rituximab Using A Thrice Weekly Dosing Schedule in B-Cell Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Demonstrates Clinical Activity and Acceptable Toxicity

John C. Byrd, Timothy J. Murphy, Robin Howard et al. · Journal of Clinical Oncology · 2001 · 511 citations

Pharmacy, Oncology, Pharmacokinetics +15

Meal‐induced peptide tyrosine tyrosine inhibition of pancreatic secretion in the rat

Gregory W. Aponte, Kathy Park, Roberta T. Hess et al. · The FASEB Journal · 1989 · 54 citations

Life Sciences, Pharmacology, Physiology +17

Peroxisome Proliferator-Activated Receptor γ Regulates the V-Ets Avian Erythroblastosis Virus E26 Oncogene Homolog 1/microRNA-27a Axis to Reduce Endothelin-1 and Endothelial Dysfunction in the Sickle Cell Mouse Lung

Bum‐Yong Kang, Kathy Park, Jennifer Kleinhenz et al. · American Journal of Respiratory Cell and Molecular Biology · 2016 · 16 citations · Full text

Medicine, Cardiology, Physiology +15

A phase I/II study examining pentostatin, chlorambucil, and theophylline in patients with relapsed chronic lymphocytic leukemia and non-Hodgkin’s lymphoma

C. R. Willis, Amy Goodrich, Kathy Park et al. · Annals of Hematology · 2006 · 13 citations

Medicine, Oncology, Pharmacology +16